FDA nomination in hand, Gottlieb prepares to disentangle himself from a long list of biopharma jobs and investments
Steve Burd (R), president and CEO, Safeway, Inc. and Scott Gottlieb (L), resident fellow at American Enterprise Institute participate in a Senate Health, Education, Labor and Pensions Committee hearing on Capitol Hill, June 11, 2009 in Washington, DC. (Credit: Mark Wilson/Getty Images)
Scott Gottlieb wasn’t idle during the eight years of the Obama administration. With Democrats in the White House and Republicans out, the former agency official turned to a busy career working with quite a range of biopharma investors and companies.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.